Education
About Us
Working with TipRanks
Follow Us
Immunome (IMNM)
NASDAQ:IMNM
Immunome (IMNM) Ownership Overview
1.61% Insiders
19.02% Mutual Funds
0.06% Other Institutional Investors
10.75% ETFs
68.55% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail, and individual investors. Approximately 29.83% of the company’s stock is owned by Institutional Investors, 1.61% is owned by Insiders, and 68.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 26, 2025 | xxxxxxxxxxxxx | $60684 | |
| Mar 26, 2025 | xxxxxxxxxxxxx | $999459 | |
| Mar 25, 2025 | xxxxxxxxxxxxx | $57470 | |
| Mar 25, 2025 | xxxxxxxxxxxxx | $103566 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $10417423 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,876,277 | Institution | 4.46% | 28,684,450 | |
| 3,124,992 | Institution | 3.59% | 23,124,941 | |
| 3,072,000 | Institution | 3.53% | 22,732,800 | |
| 2,318,030 | Institution | 2.67% | 17,153,422 | |
| 1,994,181 | Institution | 2.29% | 14,756,939 | |
| 1,957,102 | Institution | 2.25% | 14,482,555 | |
| 1,692,483 | Institution | 1.95% | 12,524,374 | |
| 1,430,018 | Institution | 1.64% | 10,582,133 | |
| 1,026,667 | Institution | 1.18% | 7,597,336 | |
| 980,925 | Institution | 1.13% | 7,258,845 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,072,000 | Institution | 3.53% | 22,732,800 | |
| 2,318,030 | Institution | 2.67% | 17,153,422 | |
| 1,994,181 | Institution | 2.29% | 14,756,939 | |
| 1,957,102 | Institution | 2.25% | 14,482,555 | |
| 1,692,483 | Institution | 1.95% | 12,524,374 | |
| 1,026,667 | Institution | 1.18% | 7,597,336 | |
| 835,438 | Institution | 0.96% | 6,182,241 | |
| 705,181 | Institution | 0.81% | 5,218,339 | |
| 551,089 | Institution | 0.63% | 4,078,059 | |
| 506,173 | Institution | 0.58% | 3,745,680 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,242,522 | Institution | 2.58% | 21,079,707 | |
| 1,811,424 | Institution | 2.08% | 13,404,538 | |
| 1,280,333 | Institution | 1.47% | 9,410,448 | |
| 1,140,319 | Institution | 1.31% | 10,718,999 | |
| 632,767 | Institution | 0.73% | 4,682,476 | |
| 367,230 | Institution | 0.42% | 2,699,141 | |
| 233,931 | Institution | 0.27% | 2,198,951 | |
| 207,902 | Institution | 0.24% | 1,954,279 | |
| 154,736 | Institution | 0.18% | 1,145,046 | |
| 124,593 | Institution | 0.14% | 921,988 |
FAQ
Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 0.06% of the company's stock is held by institutional investors, 1.61% is held by insiders, and 68.55% is held by retail investors.
What percentage of Immunome (IMNM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.06% of Immunome (IMNM) stock is held by institutional investors.
What percentage of Immunome (IMNM) stock is held by retail investors?
According to the latest TipRanks data, approximately 68.55% of Immunome (IMNM) stock is held by retail investors.
Who owns the most shares of Immunome (IMNM)?
Vanguard owns the most shares of Immunome (IMNM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.